Correction: PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
Mingyu Liu(General Hospital of Guangzhou Military Command), Li‐Min Zheng(Nanjing University), Shi‐Mei Zhuang(Sun Yat-sen University), Huiling Lin(Sun Yat-sen University), Shufeng Luo(Central South University), Jin‐Heng Li(Qingdao University of Science and Technology), Tiebang Kang(Sun Yat-sen University), Haitian Chen(Sun Yat-sen University), Lu Wang(Sun Yat-sen University), Zhu Lan, Chong Wu(Anhui Medical University), Junyu Xu, Qiaomin Hua(Biocon (Switzerland)), Zhenhong Guo(Second Military Medical University), Yulan Weng(Biocon (Switzerland))
Cited by 7
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
RAB31 marks and controls an ESCRT-independent exosome pathway
|Cell Research|2020|472
Proton conductive metal phosphonate frameworks
|Coordination Chemistry Reviews|2017|386
Genome modeling and design across all domains of life with Evo 2
|bioRxiv (Cold Spring Harbor Laboratory)|2025|206